Jan 26, 2025, 16:14
Acute Toxicity and 90-Day Mortality in Stage I NSCLC Patients Treated with SBRT – ESTRO
European Society for Radiotherapy and Oncology shared a post on X about a recent paper by Peter S.N. van Rossum et al. published in the Journal of Thorac Oncology:
“Real-World Acute Toxicity and 90-Day Mortality in Patients with Stage I NSCLC Treated with Stereotactic Body Radiotherapy, published in Journal of Thorac Oncology.
Read it before your patients.”
Authors: Peter S.N. van Rossum et al.
More posts featuring ESTRO.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 26, 2025, 16:11
Jan 26, 2025, 16:00
Jan 26, 2025, 15:49
Jan 26, 2025, 15:37
Jan 26, 2025, 15:31
Jan 26, 2025, 15:22
Jan 26, 2025, 15:04